Pharmacological Contrasts Between Caffeine and Shilajit: Implications for Performance and Health
Year: 2026
Type: article
Abstract: Background: Caffeine and Asphaltum punjabianum (Shilajit) are widely consumed bioactive substances that represent fundamentally different pharmacological paradigms. Caffeine is a well characterized methylxanthine with rapid central nervous system stimulant effects, whereas Shilajit is a complex herbomineral phytocomplex traditionally used in Ayurvedic medicine as a rasayana and adaptogen, with emerging evidence of systemic regulatory effects. Objectives: To critically synthesize contemporary preclinical and clinical literature on the pharmacokinetics, molecular mechanisms, therapeutic applications, and safety profiles of caffeine and Shilajit, and to contrast their modes of action while cautiously exploring potential interactions. Materials and Methods: A narrative review of relevant preclinical and clinical studies was conducted, focusing on the pharmacological mechanisms, biological effects, and safety considerations of caffeine and Shilajit. Literature addressing theoretical interactions and regulatory challenges was also examined. Results: Caffeine exerts acute neuromodulatory effects primarily through antagonism of adenosine A₁ and A₂A receptors, leading to transient improvements in alertness, cognition, and physical performance. In contrast, Shilajit demonstrates antioxidant, anti-inflammatory, mitochondrial, and metabolic regulatory properties, suggesting a systems-level influence on cellular resilience and bioenergetics. No experimental studies directly evaluating combined use were identified, though theoretical complementarity and potential antagonism were discussed. Key challenges include Shilajit standardization, contamination risks, and regulatory limitations. Conclusion: Caffeine and Shilajit possess distinct and well-defined pharmacological roles, with caffeine acting as an acute stimulant and Shilajit functioning as a long-term adaptogenic modulator. However, rigorous mechanistic and clinical investigations are required before any claims regarding combined or synergistic benefits can be substantiated.
Authors: Sanskar Singh, Vineet Kumar Singh, Sanjeev Kumar, Prashant Kumar Sharma, Pushpendra Kannojia, Deeksha Sharma
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W7143506791
FWCI:
Cites:
Cited by:
Related to: